Pure Global
NCT05072717

Dynamic Contrast-Enhanced Fluorescence Arthroscopy of Meniscus Pilot

Single-center Pilot Prospective Observational Study to Determine Feasibility of Assessing Meniscal Tissue Vascularity Using Dynamic Contrast-enhanced Fluorescence Arthroscopy
Dartmouth-Hitchcock Medical Center·ClinicalTrials.gov·procedureRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Knee Injuries
Drug/Device/Intervention
Perfusion with Indocyanine green
Study type
Interventional
Intervention type
procedure
Sponsor & location
Primary sponsor
Dartmouth-Hitchcock Medical Center
Location
Lebanon, United States of America
Timeline & enrollment
Phase
N/A
Start date
Jan 12, 2022
End date
Apr 30, 2023
Enrollment
30 participants
Primary outcome

Measurement of meniscal blood supply using Indocyanine green (ICG)

Summary

Single-center pilot prospective observational study to determine feasibility of assessing
 meniscal tissue vascularity using dynamic contrast-enhanced fluorescence arthroscopy

ICD-10 classifications
Injuries to the knee and lower legSprain and strain of other and unspecified parts of kneeOther spontaneous disruption of ligament(s) of kneeCrushing injury of kneeInjury to multiple structures of knee
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05072717
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT05072717 through Pure Global AI's free database. This phase not specified trial is sponsored by Dartmouth-Hitchcock Medical Center and is currently Recruiting. The study focuses on Knee Injuries. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.